InsiderClue
← All stocks

GYRE THERAPEUTICS, INC.

GYRE Net selling
CIK 0001124105 #2796 in the set updated 21 Sep 2026
Bought (120 mo)
$123.10K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.11M
$1.63M on a plan · $1.86M straight out of an exercise
Sold at will
$2.61M
6 of 116 sales
Net
−$5.99M
−$2.49M against sales at will

By person

21 insiders · 151 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Flynn James E
10% owner
—
$2.19M (5)
−$2.19M
1,113,222
0.9983%
$7.07M
−6.1%
Ma Songjiang
President
—
$1.55M (85) scheduled
−$1.55M
2,806,084
2.52%
$17.82M
−4.6%
USMAN NASSIM
Director
$27.41K (6)
$992.21K (6) scheduled
−$964.81K
11,260
0.0101%
$71.50K
—
Ye Weiguo
Chief Operating Officer
—
$869.95K (16) scheduled
−$869.95K
700,000
0.6277%
$4.45M
—
LAWLOR AUGUSTINE
Director
—
$423.51K (1)
−$423.51K
118,189
0.1060%
$750.50K
−14.9%
Luo Ying
Chief Executive Officer
—
$82.93K (2) scheduled
−$82.93K
2,565,226
2.30%
$16.29M
—
Levy Howard
Chief Medical Officer
$28.98K (4)
$1.90K (1) scheduled
+$27.08K
40,123
0.0360%
$254.78K
+24.7%
Ling Geoffrey M.D.
Director
$18.69K (1)
—
+$18.69K
31,790
0.0285%
$201.87K
—
Richard John P
Director
$17.98K (2)
—
+$17.98K
3,716
0.0033%
$23.60K
+1,620%
Williams Eddie
Director
$11.56K (1)
—
+$11.56K
34,804
0.0312%
$221.01K
+27,091%
Cai Veronica
Controller
$8.22K (1)
—
+$8.22K
7,353
0.0066%
$46.69K
+100.1%
Blouse Grant E.
Chief Scientific Officer
$7.23K (3)
—
+$7.23K
9,417
0.0084%
$59.80K
+436.9%
Miller Seline E.
SVP Finance; Interim CFO & PAO
$3.02K (2)
—
+$3.02K
6,500
0.0058%
$41.28K
+99,900%
GNI Group Ltd. entity
10% owner
—
—
—
64,005,887
57.40%
$406.44M
+14,994%
DESOUZA ERROL B
Director
—
—
—
29,801
0.0267%
$189.24K
+12,266%
Hunt Andrea
Director
—
—
—
28,228
0.0253%
$179.25K
+99,900%
Eastling Thomas Wilson
Chief Financial Officer
—
—
—
15,000
0.0135%
$95.25K
—
Payne Fletcher
Chief Financial Officer
—
—
—
4,911
0.0044%
$31.18K
+320.8%
TETLOW SHARON
Director
—
—
—
3,635
0.0033%
$23.08K
—
HILL STEPHEN A
Director
—
—
—
1,190
0.0011%
$7.56K
−13.8%
GNI Hong Kong Ltd entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Eastling Thomas Wilson
16 Apr 2025
Director
Exercised, kept
15,000
$6.93
$103.95K
Ye Weiguo
1 Apr 2025
Chief Operating Officer
Exercised, kept
50,000
$0.75
$37.50K
Ye Weiguo
27 Mar 2025
Chief Operating Officer
Exercised, kept
150,000
$0.75
$112.50K
Ye Weiguo
26 Mar 2025
Chief Operating Officer
Exercised, kept
200,000
$0.75
$150.00K
Ye Weiguo
24 Mar 2025
Chief Operating Officer
Exercised, kept
300,000
$0.75
$225.00K
USMAN NASSIM
5 Apr 2021
President & CEO
Exercised, kept
5,000
$4.63
$23.15K
Levy Howard
21 May 2019
Chief Medical Officer
Exercised, kept
4,400
$4.63
$20.37K
USMAN NASSIM
21 May 2019
President & CEO
Exercised, kept
4,400
$4.63
$20.37K
Payne Fletcher
4 Feb 2019
Chief Financial Officer
Exercised, kept
1,503
$4.63
$6.96K
USMAN NASSIM
31 Jan 2019
President & CEO
Exercised, kept
5,729
$4.63
$26.53K
Levy Howard
31 Jan 2019
Chief Medical Officer
Exercised, kept
1,500
$4.63
$6.95K
Levy Howard
26 Nov 2018
Chief Medical Officer
Exercised, kept
149
$4.63
$689.87
Levy Howard
3 May 2018
Chief Medical Officer
Exercised, kept
7,560
$4.63
$35.00K
USMAN NASSIM
4 Apr 2018
President & CEO
Exercised, kept
88
$4.63
$407.44
Payne Fletcher
26 Mar 2018
Chief Financial Officer
Exercised, kept
59
$4.63
$273.17
Show all 151 transactions →

What was left out

Form 4 filings counted 269
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 23
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 72,958,443
Sales filed before the plan box existed 6
History held since 12 Jul 2017